Default company panoramic image

Viator Technologies Inc

VTI is developing diagnostic products for photoacoustic detection and analysis of circulating cancer cells and infectious pathogens.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Columbia, MO, USA
  • Currency USD
  • Founded March 2011
  • Employees 0

Company Summary

Viator Technologies, Inc. is developing diagnostic products based on proprietary photoacoustic detection techniques, created by John Viator (co-founder).
Potential applications include:
−Photoacoustic detection of circulating tumor cells (CTCs): melanoma, breast, prostate & other cancers
−Capture CTCs for analysis for personalized medicine applications
−Photoacoustic detection of circulating infectious pathogens, including bacteria and parasi


  • Default avatar
    John Viator, Ph.D.
    President & Co-Founder

    •Associate Professor, Biological Engineering & Dermatology - University of Missouri; 15+ years of experience in biomedical optics specializing in photoacoustic technology
    •NIH Postdoctoral Fellow, Dermatology, Oregon Health & Science University, Portland, OR
    •Postdoctoral Fellow, Biomedical Engineering, Beckman Laser Institute, UC Irvine
    •Ph.D., Electrical Engineering, OGI School of Science and Engineering, Oregon Health & Science Universit

  • Default avatar
    Martin Sanders, MD.
    Chairman & Co-Founder

    •Extensive experience in biopharmaceutical product discovery, R&D
    •Involved in many early stage companies as co-founder, director, officer, private investor and venture capitalist
    •Companies involved with include the Upjohn Company, Centocor, Inc., Palingen, Inc. and Dynavax. Partner at venture capital fund Charter Life Sciences.
    •Certified by the American Board of Internal Medicine
    •M.D. , University of Chicago

  • Default avatar
    Richard Maisto
    Director & Co-Founder

    •Founding Partner, Morpheus Capital Advisors
    •Managing Director, BT Alex Brown, Smith Barney
    •Vice President, Drexel Burnham’s restructuring group
    •Involved in numerous life sciences start-ups including Proliferon, which was purchased by Alexion Pharmaceuticals
    •Served on numerous corporate boards and was a mentor to the Southern California Biomedical Council
    •Boston College, BS; Columbia Business School, MBA

  • Default avatar
    Bash Derti
    Chief Financial Officer & Co-Founder

    •Senior Vice President, Morpheus Capital Advisors
    •Co-founder, The Rubicon Group, a financial consulting firm
    •Vice President of Business Development, Broadband Sports, an internet start-up focused on sports related content and commerce
    •Investment banker, SG Cowen’s Technology and Media & Entertainment Investment Banking Groups
    •Dartmouth College, AB; Duke University, MBA


  • Default avatar
    Morrison Foerster
    Default avatar

Previous Investors

  • Default avatar
    Martin Sanders
    Default avatar
    Richard Maisto
    Default avatar
    Bash Derti